Digital Healthcare News
-
Showcase
Empatica and BARDA Join Forces to Validate Wearable System That Detects COVID-19 Before Symptoms Appear
BOSTON, June 19, 2020 /PRNewswire/ -- Digital healthcare company Empatica announces a pioneering new partnership with the Biomedical Advanced Research and Development Authority ("BARDA"), part of the Office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services (HHS), to validate an early warning system for COVID-19 and other respiratory ...
-
5 Challenges Facing UK Healthcare Organisations in 2024
As we look into the new year, the healthcare landscape in the UK is undergoing a number of changes. From digital transformation to evolving regulations, healthcare organisations across the UK are facing a number of challenges in 2024. We delve into five potential challenges confronting healthcare providers across the UK to help them prepare for the year ahead. ...
-
Inspirata Accelerates Its Growth as a Leading Provider of AI/NLP Technology in Oncology Informatics
Inspirata Inc. and FUJIFILM Corporation signed an asset purchase agreement for Fujifilm to acquire Inspirata’s Dynamyx® digital pathology technology, employees and customers, building off the proven success of the established partnership between the companies in UK and Europe. This milestone allows the Digital Pathology business to flourish with a partner who has the breadth, depth and ...
-
Digital Diagnostics Named to the 2022 CB Insights’ Digital Health 150 List
Coralville, Iowa December 7, 2022 — Digital Diagnostics – a leading AI diagnostics company on a mission to transform global healthcare – is a recipient of CB Insights’ fourth-annual Digital Health 150. The list recognizes the 150 most promising private digital health companies of 2022. “From reimagining clinical care, to leveraging tech like AR/VR to improve ...
-
Iterative Health Named to the 2022 CB Insights’ Digital Health 150 List
Iterative Health, a pioneer in precision-medicine technologies for gastroenterology, today announced that it has been named one of CB Insights’ top 150 companies in Digital Health for 2022, the second year in a row in which it has made this list. The Digital Health 150 is CB Insights’ annual ranking of the 150 most promising digital health startups in the world. Iterative Health was ...
-
Gogoa Mobility Robots featured in AlbionVC`s European HealthTech Market Map 2022
Gogoa Mobility Robots is honoured to be featured in AlbionVC's European HealthTech Market Map 2022 inside the following category: Digital Care - Device Enabled Care. Many thanks to AlbionVC and the curators of this year's 2022 European HealthTech Market Map for the mention: Sean Hewetson, Molly Gilmartin, and Christoph Ruedig. ...
-
Results of Four Studies Demonstrating Clinical, Economic Value of iRhythm’s Product Portfolio Presented at American Heart Association ’22
iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading cardiovascular diagnostics and digital healthcare solutions company focused on creating trusted solutions that detect, predict, and prevent disease, today announced the results of four clinical studies presented at the American Heart Association’s (AHA) 2022 Scientific Sessions in Chicago, IL. The studies demonstrate health economic and ...
-
Healthcare Technology Leader Laure Tessier-Delivuk Joins Inspirata as Vice President of Operations for Oncology Informatics
Oncology informatics company, Inspirata, is pleased to announce the recent addition of a new key member to the company’s leadership team. Effective November 17, 2022, Laure Tessier-Delivuk, PMP, has joined as Vice President of Operations – Oncology Informatics. Laure brings 25+ years of experience as a Healthcare Technology executive leader and a proven track record in managing ...
-
New Research Confirms that Zio by iRhythm Provides High Value From a Health Economic Perspective
iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading cardiovascular diagnostics and digital healthcare solutions company focused on creating trusted solutions that detect, predict, and prevent disease, today announced a new health economic analysis of the mSToPS study, presented at the American Heart Association’s 2022 Scientific Sessions event. The study, titled “Cost-Effectiveness ...
-
Intrasense signs a historic contract with Brazilian medical technology leader MV
Intrasense (FR0011179886 - ALINS), a specialist in medical imaging software solutions, and MV, a key global player in the development of healthcare management software, announced the signing of a new contract to deploy the innovative solutions of the Myrian platform in Brazil, Panama, Colombia and Argentina. Intrasense solutions gain strong visibility in Latin America MV, a leading provider of ...
By Intrasense
-
GE Healthcare in collaboration with Nex Cubed select six digital health start-ups for inaugural Edison Accelerator in Canada
Six digital health start-ups from five countries have officially become the first cohort of the Edison Accelerator in Canada – a program designed by GE Healthcare and delivered in collaboration with Nex Cubed to accelerate, validate, and scale innovative solutions that address important challenges in the healthcare sector. The companies all focus on applying Artificial Intelligence (AI) to ...
-
iRhythm Gains FDA Clearance for its Clinically Integrated ZEUS System
iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital healthcare solutions company focused on the advancement of cardiac care, today announced it received FDA 510(k) clearance for its ZEUS (Zio ECG Utilization Software) System for the Zio Watch. Produced in partnership with Verily, an Alphabet precision health company, the ZEUS System combines deep learned algorithms with a proven and ...
-
Molecular Health receives IVDR certification for MH Guide
Molecular Health, an international biotech IT company based in Heidelberg, Germany, has received European Union certification for its MH Guide clinical decision support software (SaaS) under the new In Vitro Diagnostics Regulation (EU) 2017/746 (IVDR). The MH Guide software, which is used in molecular pathology laboratories, is the first of its kind in Europe to receive this certification. The ...
-
Retrospective study covering 2,000 patients over 10 years using ForeseeHome AMD remote monitoring shows substantially better outcomes for patients
Manassas, VA (April 26, 2022) - Notal Vision, Inc. reported today the publication of the Analysis of Long-term visual Outcomes of ForeseeHome Remote Telemonitoring (ALOFT) study results in Ophthalmology Retina. The study showed remarkable long-term visual outcomes for patients participating in the Medicare covered, Al-enabled ForeseeHome AMD Monitoring Program, provided by the Notal Vision ...
-
Innovative AI Technology Aids Personalized Care for Diabetes Patients Needing Complex Drug Treatment
Hitachi, Ltd. (TSE: 6501, Hitachi), University of Utah Health (U of U Health), and Regenstrief Institute, Inc. (Regenstrief) today announced the development of an AI method to improve care for patients with type 2 diabetes mellitus who need complex treatment. One in 10 adults worldwide have been diagnosed with type 2 diabetes, but a smaller number require multiple medications to control blood ...
-
Notal Vision Reports Publication of First U.S. Home OCT Study Results
Manassas, VA (March 8th, 2022) - Digital healthcare provider Notal Vision today announced that results of the first U.S.-based study with its investigational home-based optical coherence tomography (OCT) platform have been published in Ophthalmology Retina1. The Notal Home OCT pipeline technology is designed to provide patient-initiated retinal OCT scans to support the management of patients with ...
-
Redox and Spire Health partner to connect respiratory RPM to US health systems
MADISON, Wis., March 2, 2022 /PRNewswire/ -- Today Redox, the company driving interoperability in healthcare, has announced a partnership with Spire Health, the leading digital healthcare company for respiratory remote patient monitoring (RPM). Together, Spire Health and Redox will integrate RPM data into health system electronic medical records (EMRs) to improve both billing and clinical ...
By Spire Health
-
Deep Lens and Hematology-Oncology Associates of Central New York Collaborate to Improve Clinical Trial Matching for Oncology Patients
“Clinical research has been a number one priority for our practice since our doors opened almost 40 years ago. We’ve worked hard to build and expand our clinical trial program so that all of our patients have every possible option to receive access to the newest therapies in development,” said Steven Duffy, MD at HOA CNY. “We’re delighted to partner with Deep Lens ...
-
Intrommune Therapeutics Names Sergi X. Trilla, MD, MBA as its Director, Corporate Strategy & Partnerships
NEW YORK, Dec. 21, 2021 (GLOBE NEWSWIRE) -- Intrommune Therapeutics, a New York-based, clinical stage biotechnology company developing a patient-friendly treatment platform for peanut and other food allergies, announced the promotion of Sergi Trilla, MD to become Director of Corporate Strategy & Partnerships. “Dr. Trilla has proven to be an invaluable asset to Intrommune since he ...
-
Deep Lens and Ventura County Hematology Oncology Specialists Partner to Expand Clinical Offering for Cancer Patients
Deep Lens and Ventura County Hematology Oncology Specialists today announced that they have entered into a strategic agreement that will expand clinical trial opportunities for patients in the Ventura county area. As part of this collaboration, Ventura County Hematology Oncology Specialists will integrate Deep Lens’ artificial intelligence (AI) based clinical trial matching solution and ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you